Todd E. Zavodnick
2017
In 2017, Todd E. Zavodnick earned a total compensation of $3.1M as Chief Commercial Officer and President, Aesthetics & Therapeutics at Revance Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $103,846 |
|---|---|
| Option Awards | $520,282 |
| Salary | $116,667 |
| Stock Awards | $2,318,000 |
| Other | $22,244 |
| Total | $3,081,039 |
Zavodnick received $2.3M in stock awards, accounting for 75% of the total pay in 2017.
Zavodnick also received $103.8K in non-equity incentive plan, $520.3K in option awards, $116.7K in salary and $22.2K in other compensation.
Rankings
In 2017, Todd E. Zavodnick's compensation ranked 3,521st out of 14,666 executives tracked by ExecPay. In other words, Zavodnick earned more than 76.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,521 out of 14,666 | 76th |
Division Manufacturing | 1,220 out of 5,768 | 79th |
Major group Chemicals And Allied Products | 336 out of 2,074 | 84th |
Industry group Drugs | 257 out of 1,730 | 85th |
Industry Pharmaceutical Preparations | 205 out of 1,329 | 85th |
Source: SEC filing on March 20, 2018.
Zavodnick's colleagues
We found three more compensation records of executives who worked with Todd E. Zavodnick at Revance Therapeutics in 2017.